RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
CMG Pharmaceutical Co Stock

CMG Pharmaceutical Co Equity 2024

CMG Pharmaceutical Co Equity

190.23 B KRW

Ticker

058820.KQ

ISIN

KR7058820002

In 2024, CMG Pharmaceutical Co's equity was 190.23 B KRW, a 2.85% increase from the 184.95 B KRW equity in the previous year.

CMG Pharmaceutical Co Aktienanalyse

What does CMG Pharmaceutical Co do?

CMG Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing CMG Pharmaceutical Co's Equity

CMG Pharmaceutical Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding CMG Pharmaceutical Co's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating CMG Pharmaceutical Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

CMG Pharmaceutical Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in CMG Pharmaceutical Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about CMG Pharmaceutical Co stock

What is the equity of CMG Pharmaceutical Co this year?

CMG Pharmaceutical Co has equity of 190.23 B KRW this year.

What was the equity of CMG Pharmaceutical Co compared to the previous year?

The equity of CMG Pharmaceutical Co has increased/decreased by 2.85% increased compared to the previous year.

What impact does a high equity have on investors of CMG Pharmaceutical Co?

A high equity is advantageous for investors of CMG Pharmaceutical Co as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of CMG Pharmaceutical Co?

A low equity can be a risk for investors of CMG Pharmaceutical Co, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of CMG Pharmaceutical Co affect the company?

An increase in equity of CMG Pharmaceutical Co can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of CMG Pharmaceutical Co affect the company?

A reduction in equity of CMG Pharmaceutical Co can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of CMG Pharmaceutical Co?

Some factors that can affect the equity of CMG Pharmaceutical Co include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of CMG Pharmaceutical Co so important for investors?

The equity of CMG Pharmaceutical Co is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can CMG Pharmaceutical Co take to change the equity?

To change equity, CMG Pharmaceutical Co can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does CMG Pharmaceutical Co pay?

Over the past 12 months, CMG Pharmaceutical Co paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, CMG Pharmaceutical Co is expected to pay a dividend of 0 KRW.

What is the dividend yield of CMG Pharmaceutical Co?

The current dividend yield of CMG Pharmaceutical Co is .

When does CMG Pharmaceutical Co pay dividends?

CMG Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of CMG Pharmaceutical Co?

CMG Pharmaceutical Co paid dividends every year for the past 0 years.

What is the dividend of CMG Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 0 KRW are expected. This corresponds to a dividend yield of 0 %.

In which sector is CMG Pharmaceutical Co located?

CMG Pharmaceutical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von CMG Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of CMG Pharmaceutical Co from 10/4/2024 amounting to 0 KRW, you needed to have the stock in your portfolio before the ex-date on 10/4/2024.

When did CMG Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 10/4/2024.

What was the dividend of CMG Pharmaceutical Co in the year 2023?

In the year 2023, CMG Pharmaceutical Co distributed 0 KRW as dividends.

In which currency does CMG Pharmaceutical Co pay out the dividend?

The dividends of CMG Pharmaceutical Co are distributed in KRW.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von CMG Pharmaceutical Co

Our stock analysis for CMG Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of CMG Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.